ADIM
ITRI icon

Alpha DNA Investment Management’s Itron ITRI Stock Holding History

Alpha DNA Investment Management’s Portfolio ITRI Stock Details ITRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,602
Closed -$492K – 223
2024
Q3 		$492K Sell
4,602
-262
-5% -$26.5K 0.18% 117
2024
Q2 		$481K Sell
4,864
-788
-14% -$79.3K 0.19% 114
2024
Q1 		$523K Buy
+5,652
New +$455K 0.19% 132

Other funds holding ITRI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Alpha DNA Investment Management's ITRI Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of Itron (ITRI) in Q4 2024, closing a stake of 4,602 shares — an estimated $492K sold.

Alpha DNA Investment Management first reported a position in ITRI in Q1 2024 and held it in 3 quarters. The position peaked at $523K in Q1 2024. 431 funds tracked by Wall St. Rank hold ITRI as of Q4 2024.

  • Alpha DNA Investment Management reported no remaining Itron position as of Q4 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 4,602 Itron shares in Q4 2024, an estimated $492K.
  • Alpha DNA Investment Management first reported a position in Itron in Q1 2024 and held it in 3 quarters.
  • Alpha DNA Investment Management's Itron position peaked at $523K in Q1 2024.
  • 431 funds tracked by Wall St. Rank held Itron as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.